Uterine cancer is one of the most common forms of cancer, and there are two distinct types. The more common type of uterine ...

The following is a summary of "Uterine cancer incidence trends and 5-year relative survival by race/ethnicity and histology among women under 50 years," published in the November 2024 issue of ...

Does Hormone Replacement Therapy Increase Cancer Risk? Hormone replacement ... Cancers Research Advocacy Group. Huntsman Cancer Institute researchers studied estrogen receptor mutations and its ...

Ovarian cancer is a relatively manageable malignancy ... a less than optimally specific biomarker panel in defined higher risk groups to increase the positive predictive value.

For example, the risk for endometrial cancer increases sevenfold with a BMI of more than ... The participants were divided into two groups and matched by factors including age and sex. One group of ...

This closely follows the recent publication of the expanded NCCN Guidelines® for Genetic/Familial High-Risk Assessment: ...

Pembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery ... DFS not reached in either group. For pembrolizumab and placebo ...

The reminders are everywhere. When a woman turns 40, doctors say she should begin receiving yearly mammograms to detect ...

Uterine cancer is one of the most common forms of cancer, and there are two distinct types. The more common type of uterine ...

MONDAY, Oct. 21, 2024 (HealthDay News) -- Pembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients ...